Botanix Pharmaceuticals (ASX:BOT) has some material news pending in the form of clinical trial results.
The ASX has granted the company a trading halt to prepare, with its shares placed in pre-open.
The halt will remain in place until the opening of trade on Tuesday 4th July 2017, or earlier if an announcement is made to the market.